LOJUJTA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LOJUJTA, covering 2026-06-25 to 2026-06-25. Get the full timeline:
Most recent: EMA Authorised: Lojuxta (Lomitapide) — Chiesi Farmaceutici SpA
1 regulatory and trial event tracked for LOJUJTA, covering 2026-06-25 to 2026-06-25. Get the full timeline:
Most recent: EMA Authorised: Lojuxta (Lomitapide) — Chiesi Farmaceutici SpA